Bonerge Lifescience
Bonerge Lifescience is a privately held B2B ingredient manufacturer producing proprietary branded nutraceutical and cosmeceutical actives (including fisetin, urolithin A, S-equol, and dihydroberberine) for global supplement and cosmetic brand manufacturers, supported by ODM and CDMO services.
- Company typePrivate
- Founded2022
- HeadquartersOntario, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bonerge Lifescience does
Bonerge Lifescience is a privately held B2B ingredient manufacturer producing proprietary branded nutraceutical and cosmeceutical actives for global supplement, functional food, and cosmetic brand customers. The company's portfolio spans seven core branded ingredients (BeFisetin fisetin, EquoYouth S-Equol, StanYouth Urolithin A, GlucoSober dihydroberberine, Amuctive Akkermansia muciniphila, MitoSober PQQ, and QinMito L-Ergothioneine), a cosmeceutical line for topical beauty-from-within applications, a set of classic polyphenol ingredients, and synergistic formulations such as StanYouth CR3. Underlying these products are three proprietary delivery platforms (Oil-Soluble emulsification, Water-Soluble liposomal systems, and a High-Bioavailability Softgel platform) that claim multi-fold bioavailability improvements versus conventional forms.
Revenue is generated through one-time ingredient sales to B2B customers combined with ODM and CDMO service engagements that bundle formulation development, scale-up, and clinical trial expertise for brand partners. Go-to-market is enterprise field sales supplemented by content marketing, scientific conference presentations, and trade show presence at SupplySide Global/East/West, Natural Products Expo West, and Vitafoods Europe. Key customer segments are women's health supplement brands, longevity and anti-aging manufacturers, metabolic health companies (including GLP-1 companion nutrition), and beauty/cosmetics brands, with ODM/CDMO clients representing an additional business unit.
The company is headquartered at Zhongjian Smart Valley, Yuelu District, Changsha, Hunan Province, China, with U.S. sales contact infrastructure, and identifies 11-50 employees. It has achieved recent regulatory and clinical milestones including Self-Affirmed GRAS status for BeFisetin (April 2025) and EquoYouth S-Equol (December 2025), a 108-participant senolytic clinical trial for skin rejuvenation, a published collaboration with Mayo Clinic on IL-23R as an anti-aging biomarker, and recognition from the China Astronaut Scientific Research and Training Center for circadian rhythm research on StanYouth.
Bonerge Lifescience firmographics
Firmographics- Name
- Bonerge Lifescience
- Legal name
- Bonerge Lifescience
- Website
- https://bonerge.com
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bonerge Lifescience is a privately held B2B ingredient manufacturer producing proprietary branded nutraceutical and cosmeceutical actives (including fisetin, urolithin A, S-equol, and dihydroberberine) for global supplement and cosmetic brand manufacturers, supported by ODM and CDMO services.
- Ownership category
- akta.pro rank
Bonerge Lifescience industry classification
Industry- Product category
- Nutraceutical Ingredients
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Healthy Aging & Cognitive Support Supplements (CRADAGAM)
- akta.pro secondary industries
- Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots) (CRADAGAI), Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)
Keywords
Where Bonerge Lifescience is headquartered
LocationHeadquarters
- HQ city
- Ontario
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Bonerge Lifescience business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Branded Ingredient Sales: Sale of proprietary branded nutraceutical ingredients including BeFisetin Fisetin, StanYouth Urolithin A, EquoYouth S-Equol, Dihydroberberine, Amuctive Akkermansia, MitoSober PQQ, QinMito L-Ergothioneine. B2B supplier model to supplement and cosmetic manufacturers.
- Cosmeceutical Ingredient Sales: Sale of bioactive ingredients for topical cosmetic applications including Fisetin Cosmetic, Urolithin A Cosmetic, L-Ergothionine Cosmetic.
- ODM Services: End-to-end formulation and manufacturing support including competitor analysis, consumer research, formula development, sampling, testing, optimization, and commercial-scale production.
- CDMO Services: Contract development and manufacturing services for patented active ingredients, exclusive formulations, novel delivery systems, and clinical trial expertise.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Bonerge Lifescience product offering
Product offeringCore offering
Bonerge Lifescience is a B2B ingredient manufacturer that develops, produces, and supplies nutraceutical and cosmeceutical raw materials to dietary supplement and personal care brands. The portfolio spans branded, clinically-supported longevity actives (such as fisetin, urolithin A, S-equol, L-ergothioneine, and PQQ) plus classic polyphenolic ingredients (apigenin, luteolin, resveratrol, polydatin, mangiferin, spermidine), delivered through proprietary bioavailability platforms. The company also offers ODM and CDMO services for finished dietary supplement products, including custom formulation, softgel encapsulation, and full turnkey brand support.
Product overview
Bonerge Lifescience is an innovative manufacturer providing comprehensive turn-key solutions in the nutraceutical and cosmeceutical ingredients industries. The company operates a multi-tiered product portfolio consisting of: (1) Branded Ingredients including EquoYouth™ S-Equol, StanYouth® Urolithin A, BeFisetin® Fisetin, Dihydroberberine (GlucoSober™), Amuctive™ Akkermansia, MitoSober® PQQ, and QinMito® L-Ergothioneine; (2) Cosmeceutical Ingredients for beauty-from-within applications; (3) Classic Ingredients including Apigenin, Luteolin, Genistein, Polydatin, Resveratrol, Mangiferin, and Spermidine; (4) Synergistic Formulations such as StanYouth® CR3; (5) ODM & CDMO manufacturing services; and (6) Proprietary Technology Platforms (Oil Soluble, Water Soluble, High-Bioavailability Softgel) that enhance bioavailability of active ingredients. The company focuses on ingredients for Ageless Energy, Healthspan, and Longevity.
Differentiator
Problem solved
Functional benefit
Brands
- BeFisetin®: Premium branded fisetin ingredient - the first and only SA-GRAS certified fisetin with >99% purity.
- EquoYouth™
- StanYouth®
- Amuctive™
- Dihydroberberine
- MitoSober®
- QinMito®
- GlucoSober™
Products and services
- EquoYouth™ S-Equol
Quantifiable outcome
- 54x higher bioavailability compared to berberine for dihydroberberine
- +4 more outcomes
Companies that use Bonerge Lifescience
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles3 records
Bonerge Lifescience technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature9 records
Bonerge Lifescience partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- NUS Centre for Healthy LongevitymajorConference sponsor and participant at CHL Scientific Conference focused on healthy longevity supplements. Engaged with leading longevity researchers including Dr. Brian Kennedy, Dr. David Sinclair, Dr. Guido Kroemer, and Dr. Laura Niedernhofer to explore senolytic mechanisms and mitophagy research.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Bonerge Lifescience competitors and assessment
Company assessmentDirect peers
- AIDP: US-based specialty ingredient supplier focused on branded, science-backed nutraceutical ingredients for healthy aging, cognitive, and metabolic health. Highly comparable mid-size competitor in Bonerge's target categories with established North American distribution.
- Amazentis / Timeline Nutrition: Pioneer of branded, clinically-validated urolithin A ingredient (Mitopure) targeting mitochondrial health and longevity. Directly overlaps Bonerge's StanYouth® Urolithin A in active ingredient, indication (longevity), and B2B ingredient-supply model.
- Sabinsa: Globally recognized manufacturer of standardized nutraceutical ingredients (curcuminoids, bioactives) with branded SKUs, clinical backing, and a global B2B sales network. Closely comparable to Bonerge's model of branded, clinically-supported nutraceutical ingredients sold to supplement brands.
- Maypro Ingredients: Specialty nutraceutical ingredient distributor sourcing and marketing branded ingredients (many from Asia) to US supplement brands. Comparable business model to Bonerge's B2B branded-ingredient sales, particularly for the women's health and longevity categories.
- ChromaDex: Public ingredient company behind Niagen® (nicotinamide riboside) and Tru Niagen, with strong IP and clinical evidence in the NAD+/longevity category. Highly comparable as a science-driven, branded-ingredient supplier in the longevity supplement market.
- Sami Labs: Vertically integrated nutraceutical ingredient manufacturer with branded ingredients (e.g., BioPerine, Saberry) sold globally to supplement brands. Comparable B2B model with branded, clinically backed ingredients spanning metabolic, anti-aging, and women's health.
Broad incumbents
- Kyowa Hakko Bio: Major Japanese fermentation-based ingredient manufacturer (e.g., Cognizin citicoline, branded amino acids) supplying global nutraceutical brands. Comparable as a fermentation-purity-focused, branded-ingredient supplier and a credible competitor in longevity and metabolic actives.
- Lonza Capsules & Health Ingredients: Global CDMO and ingredient manufacturer offering delivery technologies (lipid multiparticulates, softgels) and bioavailability-enhanced ingredients to nutraceutical and pharma customers. Competes with Bonerge's delivery platforms and CDMO service lines at a much larger scale.
Emerging players
- BioActor: Dutch developer and supplier of proprietary branded nutraceutical ingredients for metabolic, bone, and muscle health. Comparable as a smaller European science-driven ingredient supplier overlapping Bonerge's metabolic and women's health segments.
- NuLivScience: Specialty ingredient company focused on branded, clinically-validated longevity and metabolic health actives (e.g., PeptiStrong). Similar size and positioning as Bonerge — emerging branded-ingredient supplier targeting the same healthspan supplement market.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Bonerge Lifescience social profiles
Digital presenceBonerge Lifescience compliance and trust
Trust signalCompliance3 records
Bonerge Lifescience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bonerge Lifescience leadership team
Management profileNumber of profiles
Profiles1 record
Bonerge Lifescience funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bonerge Lifescience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bonerge Lifescience
What does Bonerge Lifescience do?
Bonerge Lifescience is a B2B ingredient manufacturer that develops, produces, and supplies nutraceutical and cosmeceutical raw materials to dietary supplement and personal care brands. The portfolio spans branded, clinically-supported longevity actives (such as fisetin, urolithin A, S-equol, L-ergothioneine, and PQQ) plus classic polyphenolic ingredients (apigenin, luteolin, resveratrol, polydatin, mangiferin, spermidine), delivered through proprietary bioavailability platforms. The company also offers ODM and CDMO services for finished dietary supplement products, including custom formulation, softgel encapsulation, and full turnkey brand support.
Is Bonerge Lifescience a public or private company?
Bonerge Lifescience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bonerge Lifescience founded?
Bonerge Lifescience was founded in 2022. It employs 11 to 50 people.
Where is Bonerge Lifescience based?
Bonerge Lifescience is headquartered in Ontario, United States, in the North America region.
How does Bonerge Lifescience make money?
Four revenue lines are on record. Branded Ingredient Sales are the primary driver. The others are cosmeceutical Ingredient Sales, ODM Services and CDMO Services.
Who are Bonerge Lifescience's main competitors?
Direct peers on record are AIDP, Amazentis / Timeline Nutrition, Sabinsa, Maypro Ingredients, ChromaDex and Sami Labs. Broad incumbents are Kyowa Hakko Bio and Lonza Capsules & Health Ingredients. Emerging players are BioActor and NuLivScience.
Does Bonerge Lifescience have an API?
No public API is recorded for Bonerge Lifescience.
What industry is Bonerge Lifescience in?
Bonerge Lifescience's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is CRADAGAM, Healthy Aging & Cognitive Support Supplements, with a secondary code of CRADAGAI, Functional Foods & Supplement Formats (Gummies, Chews, Powders, Shots). Its NAICS code is 42421 and its SIC code is 5122.